Moneycontrol PRO
HomeNewsOrchidpharma

Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

Jump to
  • Buy Orchid Chemicals, SKS Micro, Punj Lloyd: Agarwal

    In CNBC-TV18's popular show Bull's Eye, Rajesh Agarwal, Eastern Financiers shares trading strategy of the day.

  • SP Tulsian upbeat on Orchid Chemical

    SP Tulsian of sptulsian.com is positive on Orchid Chemical from a long term perspective.

  • Buy Essar Oil, Orchid Chem; short IVRCL: Aashish Tater

    In CNBC-TV18's popular show Bull's Eye, Aashish Tater, FortuneWizard.com shares trading strategy of the day.

  • Tata Motors, SAIL, UB: Check out Tulsian's picks

    S P Tulsian of sptulsian.com says if SAIL's results are a reflection of Tata Steel's numbers, then they too could post very poor numbers.

  • Buy Indiabulls Real Estate, Orchid Chemicals, RCF: Tater

    In CNBC-TV18's popular show Bull's Eye, Aashish Tater of FortuneWizard.com shares trading strategy of the day.

  • Bull's eye: Buy RCF, Indiabulls Real; short DLF, IDFC

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's eye: Buy Zee News, Gati, Uflex, short Pantaloon

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Aditya Agarwal bullish on Educomp

    Aditya Agarwal, Way2Wealth is bullish on Educomp. Orchid Chemicals can be one counter in which long positions can be initiated.

  • Bull's eye: Buy Infotech, Delta Corp, CMC, NTPC

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Buy Titan Ind, Dr Reddy‘s Labs, Century Textile: Merani

    In CNBC-TV18's popular show Bull's Eye, Nooresh Merani, AMSEC Research shares trading strategy of the day.

  • Bull's eye: Buy Rolta, Shree Renuka, Titan, Pantaloon

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Two pharma stocks that can improve health of your portfolio

    Ranbaxy and Cipla were at 52 week highs on Monday. Kour expects Cipla to perform well going ahead. She is bullish on this stock; however, she is cautious on Ranbaxy.

  • Buy Astrazeneca Pharma, Prime Focus, Marico Ind

    In CNBC-TV18's popular show Bull's Eye, Aashish Tater, Fort Share Broking shares trading strategy of the day.

  • Bull's eye: Buy Orchid Chem, Voltas, short NCC, Tech Mah

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Bull's eye: Buy IGL, Lupin; short Bajaj Auto, Hind Zinc

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • IFCI may settle around Rs 22-23: SP Tulsian

    IFCI may settle around Rs 22-23, says SP Tulsian, sptulsian.com.

  • Buy Fame India, Orchid Chemical: SP Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

  • Sudarshan Sukhani bullish Cairn India

    Sudarshan Sukhani of s2analytics.com is bullish Cairn India. It is now breaking out of that Rs 340 resistance; it has already done that. I think it will do it decisively. We want to be long in this.

  • Bull's eye: Buy Orchid Chem, Cairn, Voltas, India Cements

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

  • Orchid Chemicals can move to Rs 125- 128: SP Tulsian

    Orchid Chemicals can move to Rs 125-128 in the near-term says SP Tulsian, sptulsian.com.

  • Exit Orchid Chemicals, hold Glenmark Pharma: Sukhani

    Sudarshan Sukhani, s2analytics.com is of the view that exit Orchid Chemicals close to Rs 125-130. Stay invested in Glenmark Pharma.

  • Buy United Spirits, Gabriel India, Orchid Chem: SP Tulsian

    In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares trading strategy of the day.

  • Buy Apollo Tyre, Hindustan Zinc, Orchid Chem: Parag Doctor

    In CNBC-TV18's popular show Bull's Eye, Parag Doctor, Keynote Capital shares trading strategy of the day.

  • Reliance Capital an outperformer, says Sukhani

    Reliance Capital is an outperformer, says Sudarshan Sukhani of s2analytics.com. It is a much better chart. It‘s just making a fairly bullish pattern and willing to breakout assuming that we go through one or two day choppiness and then resume the up move.

  • Bull's eye: Buy United Spirits, ONGC, Orchid Chemical, IDFC

    Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347